Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
نویسندگان
چکیده
منابع مشابه
Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
INTRODUCTION Erythropoiesis-Stimulating Agents (ESA) are hypothesized to increase cardiovascular mortality in patients with chronic kidney disease. One of the proposed mechanisms is the elevation of blood pressure (BP) by ESA. Therefore, we aimed to determine whether the use of ESA was associated with antihypertensive treatment and higher BP. MATERIALS AND METHODS In this cohort 502 incident ...
متن کاملEvaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.
BACKGROUND Inadequate anaemia correction (haemoglobin (Hb) <11 g/dl without receiving an erythropoiesis-stimulating agent (ESA) is common in pre-dialysis patients, but little is known about its determinants. We used data from the French end-stage renal disease (ESRD) registry to investigate these determinants and the patients' anaemia status 1 year after starting dialysis. METHODS Pre-dialysi...
متن کاملSystematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients.
BACKGROUND One of the cardinal symptoms of anemia in chronic kidney disease (CKD) patients is fatigue. Recently, results from Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) raised questions about the role of erythropoiesis-stimulating agents (ESAs) in improving fatigue and the appropriate hemoglobin (Hb) target in anemic patients with CKD. These discussions should be conside...
متن کاملEffect of long-acting erythropoiesis-stimulating agents on hemoglobin levels at the initiation of dialysis
Background: The goal of the present study was to explore the differences in effects between erythropoiesisstimulating agent (ESA) types on hemoglobin (Hb) level at the initiation of maintenance dialysis. Methods: This was a cross-sectional study. From January 2006 to October 2012, 2920 patients with end-stage kidney disease commenced hemodialysis (HD) at nine participating hospitals. The criter...
متن کاملA meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis
Background. Erythropoiesis-stimulating agents (ESAs) such as epoetin alfa and beta, and darbepoetin alfa have improved the management of anaemia secondary to chronic kidney disease. Numerous studies have reported a dose reduction when patients receiving dialysis were converted from epoetin to darbepoetin alfa using the starting dose conversion of 200:1 as indicated on the prescribing label by t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLoS ONE
سال: 2013
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0084848